Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
544
Views
14
CrossRef citations to date
0
Altmetric
Review

Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease

Pere Almagro1 Multimorbidity Patient Unit, Service of Internal Medicine, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8476-4942
ORCID Icon,
Ramon Boixeda2 Service of Internal Medicine, Hospital de Mataró-CSDM, Barcelona, Mataró, SpainORCID Iconhttps://orcid.org/0000-0002-5330-9971
ORCID Icon,
Jesús Diez-Manglano3 Service of Internal Medicine, Hospital Royo Villanova, Zaragoza, SpainORCID Iconhttps://orcid.org/0000-0002-3132-2171
ORCID Icon,
María Gómez-Antúnez4 Service of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Francisco López-García5 Service of Internal Medicine, Hospital General Universitario de Elche, Alicante, Elche, Spain
&
Jesús Recio6 Service of Internal Medicine, Hospital Quironsalud València, Valencia, SpainORCID Iconhttps://orcid.org/0000-0001-8640-9015
ORCID Icon
Pages 755-764 | Published online: 14 Apr 2020

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Yinhua Luo, Ni Tan, Jingbo Zhao & Yuanhong Li. (2022) A Nomogram for Predicting In-Stent Restenosis Risk in Patients Undergoing Percutaneous Coronary Intervention: A Population-Based Analysis. International Journal of General Medicine 15, pages 2451-2461.
Read now
Komal Malik, Susana Diaz-Coto, Maria de la Asunción Villaverde, Pablo Martinez-Camblor, Annie Navarro-Rolon, Francisco Pujalte, Alejandro De la Sierra & Pere Almagro. (2022) Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2577-2587.
Read now
Jia-Jie Wang. (2021) Risk of Coronary Heart Disease in People with Chronic Obstructive Pulmonary Disease: A Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2939-2944.
Read now

Articles from other publishers (11)

Yanqi Li, Huiqiu Zheng, Wenyan Yan, Ning Cao, Tao Yan, Hao Zhu & Han Bao. (2023) The impact of chronic obstructive pulmonary disease on the prognosis outcomes of patients with percutaneous coronary intervention or coronary artery bypass grafting: A meta-analysis. Heart & Lung 60, pages 8-14.
Crossref
Anastasia Papaporfyriou, Konstantinos Bartziokas, Daniela Gompelmann, Marco Idzko, Evangelia Fouka, Stavrina Zaneli, Petros Bakakos, Stelios Loukides & Andriana I. Papaioannou. (2023) Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy. Life 13:6, pages 1299.
Crossref
Ecaterina Luca & Nicolae Bodrug. (2022) The frequency of pulmonary hypertension in chronic obstructive pulmonary disease of geriatric patients: a narrative literature review. The Egyptian Journal of Internal Medicine 34:1.
Crossref
Xiao-Fang Li, Cheng-Quan Wan & Yi-Min Mao. (2022) Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease. Frontiers in Medicine 9.
Crossref
M. E. Statsenko, S. V. Turkina & Yu. E. Lopushkova. (2022) Possibilities of drug correction of the state of the main arteries and microcirculation in patients with chronic heart failure and chronic obstructive pulmonary disease. Meditsinskiy sovet = Medical Council:17, pages 70-78.
Crossref
Andreas Casselbrant, Artur Fedorowski, Sophia Frantz, Gunnar Engström, Per Wollmer & Viktor Hamrefors. (2022) Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease. PLOS ONE 17:3, pages e0264376.
Crossref
Ying-Yi Chen, Tsai-Chung Li, Chia-Ing Li, Shih-Pin Lin & Pin-Kuei Fu. (2022) Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program. Journal of Personalized Medicine 12:2, pages 299.
Crossref
Allison Martin, Robert J Hancox, Catherina L Chang, Richard Beasley, Jeremy Wrobel, Vanessa McDonald, Claudia C Dobler, Ian A Yang, Claude S Farah, Belinda Cochrane, Graham S Hillis, Caroline Polak Scowcroft, Ashutosh Aggarwal, Gian Luca Di Tanna, Grace Balicki, Shane Galgey & Christine Jenkins. (2021) Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD. BMJ Open 11:8, pages e053446.
Crossref
Lu Zhou, Yingmin Tao, Huichu Li, Yue Niu, Liang Li, Haidong Kan, Juan Xie & Renjie Chen. (2021) Acute effects of fine particulate matter constituents on cardiopulmonary function in a panel of COPD patients. Science of The Total Environment 770, pages 144753.
Crossref
Paolo Groff, Giuseppina Petrelli, Paolo Giorgini, Roberto Pilotti, Vito Maurizio Parato & Andrea Fabbri. (2021) Clinical heterogeneity of a population of patients admitted to the Emergency Department with a diagnosis of COPD-exacerbation: Relevance of cardiovascular comorbidities. Emergency Care Journal 17:1.
Crossref
Mark Greer & Tobias Welte. (2020) Chronic Obstructive Pulmonary Disease and Lung Transplantation. Seminars in Respiratory and Critical Care Medicine 41:06, pages 862-873.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.